These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 26588439)

  • 1. Corticotropin releasing hormone and Urocortin 2 activate inflammatory pathways in cultured trophoblast cell lines.
    Novembri R; De Clemente C; Funghi L; Torricelli M; Voltolini C; Challis JR; Petraglia F
    Eur J Obstet Gynecol Reprod Biol; 2015 Dec; 195():200-205. PubMed ID: 26588439
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of signaling molecules mediating corticotropin-releasing hormone-R1alpha-mitogen-activated protein kinase (MAPK) interactions: the critical role of phosphatidylinositol 3-kinase in regulating ERK1/2 but not p38 MAPK activation.
    Punn A; Levine MA; Grammatopoulos DK
    Mol Endocrinol; 2006 Dec; 20(12):3179-95. PubMed ID: 16959871
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Corticotropin-releasing hormone and urocortin promote phagocytosis of rat macrophages through convergent but distinct pathways.
    Wang WC; Zhang XZ; Liu DW; Qiu J; Wang XH; Zhou JH
    Life Sci; 2015 Feb; 122():100-7. PubMed ID: 25534437
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Changes in placental CRH, urocortins, and CRH-receptor mRNA expression associated with preterm delivery and chorioamnionitis.
    Torricelli M; Novembri R; Bloise E; De Bonis M; Challis JR; Petraglia F
    J Clin Endocrinol Metab; 2011 Feb; 96(2):534-40. PubMed ID: 21106714
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Urocortin 2 role in placental and myometrial inflammatory mechanisms at parturition.
    Voltolini C; Battersby S; Novembri R; Torricelli M; Severi FM; Petraglia F; Norman JE
    Endocrinology; 2015 Feb; 156(2):670-9. PubMed ID: 25426872
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of urocortin 2 and urocortin 3 on IL-10 and TNF-α expression and secretion from human trophoblast explants.
    Novembri R; Torricelli M; Bloise E; Conti N; Galeazzi LR; Severi FM; Petraglia F
    Placenta; 2011 Dec; 32(12):969-74. PubMed ID: 22000474
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hypoxia and preeclampsia: increased expression of urocortin 2 and urocortin 3.
    Imperatore A; Rolfo A; Petraglia F; Challis JR; Caniggia I
    Reprod Sci; 2010 Sep; 17(9):833-43. PubMed ID: 20616367
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Urocortin, but not corticotropin-releasing hormone (CRH), activates the mitogen-activated protein kinase signal transduction pathway in human pregnant myometrium: an effect mediated via R1alpha and R2beta CRH receptor subtypes and stimulation of Gq-proteins.
    Grammatopoulos DK; Randeva HS; Levine MA; Katsanou ES; Hillhouse EW
    Mol Endocrinol; 2000 Dec; 14(12):2076-91. PubMed ID: 11117536
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Urocortin induces interleukin-6 release from rat cardiomyocytes through p38 MAP kinase, ERK and NF-kappaB activation.
    Huang M; Kempuraj D; Papadopoulou N; Kourelis T; Donelan J; Manola A; Theoharides TC
    J Mol Endocrinol; 2009 May; 42(5):397-405. PubMed ID: 19211730
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Urocortin II is expressed in human pregnant myometrial cells and regulates myosin light chain phosphorylation: potential role of the type-2 corticotropin-releasing hormone receptor in the control of myometrial contractility.
    Karteris E; Hillhouse EW; Grammatopoulos D
    Endocrinology; 2004 Feb; 145(2):890-900. PubMed ID: 14592950
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protein kinase A-induced negative regulation of the corticotropin-releasing hormone R1alpha receptor-extracellularly regulated kinase signal transduction pathway: the critical role of Ser301 for signaling switch and selectivity.
    Papadopoulou N; Chen J; Randeva HS; Levine MA; Hillhouse EW; Grammatopoulos DK
    Mol Endocrinol; 2004 Mar; 18(3):624-39. PubMed ID: 14657255
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Urocortins exhibit differential effects on PGE2 and PGF2α output via CRHR2 in human myometrium.
    You X; Chen Z; Sun Q; Yao R; Gu H; Ni X
    Reproduction; 2021 May; 162(1):11-20. PubMed ID: 33929340
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Corticotropin-releasing hormone and urocortin induce secretion of matrix metalloproteinase-9 (MMP-9) without change in tissue inhibitors of MMP-1 by cultured cells from human placenta and fetal membranes.
    Li W; Challis JR
    J Clin Endocrinol Metab; 2005 Dec; 90(12):6569-74. PubMed ID: 16174714
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Corticotropin releasing hormone modulates endotoxin-induced inflammatory cytokine expression in human trophoblast cells.
    Wang W; Nan X; Ji P; Dow KE
    Placenta; 2007 Oct; 28(10):1032-8. PubMed ID: 17568667
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Specificity and regulation of extracellularly regulated kinase1/2 phosphorylation through corticotropin-releasing factor (CRF) receptors 1 and 2beta by the CRF/urocortin family of peptides.
    Brar BK; Chen A; Perrin MH; Vale W
    Endocrinology; 2004 Apr; 145(4):1718-29. PubMed ID: 14670995
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intracellular mechanisms regulating corticotropin-releasing hormone receptor-2beta endocytosis and interaction with extracellularly regulated kinase 1/2 and p38 mitogen-activated protein kinase signaling cascades.
    Markovic D; Punn A; Lehnert H; Grammatopoulos DK
    Mol Endocrinol; 2008 Mar; 22(3):689-706. PubMed ID: 18048641
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protective effects of the urocortin homologues stresscopin (SCP) and stresscopin-related peptide (SRP) against hypoxia/reoxygenation injury in rat neonatal cardiomyocytes.
    Chanalaris A; Lawrence KM; Stephanou A; Knight RD; Hsu SY; Hsueh AJ; Latchman DS
    J Mol Cell Cardiol; 2003 Oct; 35(10):1295-305. PubMed ID: 14519439
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Urocortin and corticotrophin-releasing hormone receptor type 2 mRNA are highly expressed in deep infiltrating endometriotic lesions.
    Carrarelli P; Luddi A; Funghi L; Arcuri F; Batteux F; Dela Cruz C; Tosti C; Reis FM; Chapron C; Petraglia F
    Reprod Biomed Online; 2016 Oct; 33(4):476-483. PubMed ID: 27567427
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Urocortin 2 and urocortin 3 are expressed by the human placenta, deciduas, and fetal membranes.
    Imperatore A; Florio P; Torres PB; Torricelli M; Galleri L; Toti P; Occhini R; Picciolini E; Vale W; Petraglia F
    Am J Obstet Gynecol; 2006 Jul; 195(1):288-95. PubMed ID: 16626608
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of corticotropin-releasing hormone and stresscopin on vascular endothelial growth factor mRNA expression in cultured early human extravillous trophoblasts.
    Wakahashi S; Nakabayashi K; Maruo N; Yata A; Ohara N; Maruo T
    Endocrine; 2008 Apr; 33(2):144-51. PubMed ID: 18484196
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.